Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication for conducting the 19th AGM of the Company by VC/OAVM.22-08-2023
22-08-2023
Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation made at Motilal Oswal 19th Annual Global Investor Conference, 2023.21-08-2023
Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Earning Conference Call held on Friday, 11 August, 2023.18-08-2023
Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Allotment
Allotment of 40,000 Equity Shares under ESOP 2016 Scheme.18-08-2023
Global Health Ltd - 543654 - Disclosure Pursuant To Proviso To Regulation 30(4)(I)(D) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended ('Listing Regulations')
Pursuant to proviso to Regulation 30(4)(i)(d) read with Para B of Part A of Schedule III of the Listing Regulations and SEBI Circular dated 13 July, 2023, please find the attached Intimation in this regard.17-08-2023
Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation for Schedule of Analysts Meeting16-08-2023
Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation for Schedule of Analyst/ Institutional Investor Meeting14-08-2023
Q1FY24 Quarterly Result Announced for Global Health Ltd.
Healthcare Facilities company Global Health announced Q1FY24 results: Total income of Rs 7,945 million; growth of 26.8% YoY EBITDA of Rs 1,993 million; growth of 40.7% YoY EBITDA margins improved from 22.6% in Q1FY23 to 25.1% in Q1FY24 Profit after tax was at Rs 1,020 million; up by 73.7% YoY Average Occupied bed days increased by 16.2% YoY, representing an occupancy of 58.1% in Q1FY24 on increased bed capacity. ARPOB grew by 7.1% YoY to Rs 63,148; In-patient volume increased by 19.4% and Out-patient volume increased by 17.5% YoY. Developing hospitals (Medanta Lucknow and Medanta Patna) revenue share increased from 23.4% in Q1FY23 to 28.9% in Q1FY24 amounting to Rs 2,297 million. EBITDA share increased from 22.6% in Q1FY23 to 31.4% in Q1FY24 amounting to Rs 720 million. Revenue from international patients increased by 45% YoY to Rs 477 million driven by increased volume and realization. In-house out-patient pharmacy business continues to register strong growth. Revenue increased by 43% YoY from Rs 186 million in Q1FY23 to Rs 266 million in Q1FY24. Commenting on Q1FY24 results, Pankaj Sahni, Group CEO and Director said, “We are excited to partner with DLF to build a new 400-bed multi-super specialty hospital in South Delhi. This hospital will allow us to serve patients across the entire NCR belt by seamlessly linking our facilities in Gurgaon, Delhi, and Noida. We are also pleased to report our Q1FY24 financial performance. The Company continues to deliver strong YoY and sequential growth driven by higher patient volumes and improvement in realization.” Result PDF14-08-2023
Global Health Ltd - 543654 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Audio Recording
Audio Recording Link of Earning Conference Call held on Friday, August 11, 2023 hosted by JM Financial.11-08-2023
Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Monitoring Agency Report for quarter ended June 30, 2023.11-08-2023